A 28-year-old woman presents with severe hypoglycemia (blood glucose 35 mg/dL) after a 48-hour fast. Her liver biopsy shows normal glycogen stores. Regarding the enzymes and pathways involved in maintaining her blood glucose, all of the following statements are true EXCEPT:

Explanation

## Gluconeogenesis Regulation in Fasting Hypoglycemia **Key Point:** This question tests understanding of the key regulatory enzymes of gluconeogenesis and their allosteric control. The correct answer is the statement about fructose-1,6-bisphosphatase that is INCORRECT. ## Analysis of Each Statement ### Statement 1: Pyruvate Carboxylase — TRUE Pyruvate carboxylase catalyzes: $$\text{Pyruvate} + \text{CO}_2 + \text{ATP} \rightarrow \text{Oxaloacetate} + \text{ADP} + \text{Pi}$$ This is the first committed, irreversible step of gluconeogenesis. It is activated by acetyl-CoA (a signal of energy availability) and is essential for converting all gluconeogenic substrates to oxaloacetate. ### Statement 2: Fructose-1,6-bisphosphatase — INCORRECT ✗ **High-Yield:** This is the trap. The statement claims FBPase is **inhibited by AMP and activated by ATP**. This is BACKWARDS. **Correct regulation:** - **Activated by:** ATP, citrate (signals of energy abundance) - **Inhibited by:** AMP, ADP, fructose-2,6-bisphosphate (F-2,6-BP) — signals of energy depletion FBPase catalyzes: $$\text{Fructose-1,6-bisphosphate} \rightarrow \text{Fructose-6-phosphate} + \text{Pi}$$ This is a key regulatory step. During fasting (high AMP/ATP ratio), FBPase should be ACTIVE to promote gluconeogenesis, not inhibited. **Mnemonic:** **"AMP Opposes Anabolism"** — AMP inhibits biosynthetic enzymes like FBPase and activates catabolic pathways. ### Statement 3: Glucose-6-Phosphatase — TRUE Glucose-6-phosphatase is the final enzyme of gluconeogenesis: $$\text{Glucose-6-phosphate} \rightarrow \text{Glucose} + \text{Pi}$$ It is present in liver and kidney (minor), but **absent in muscle**. This is why muscle cannot release free glucose into blood despite having glycogenolysis capacity — muscle glucose-6-phosphate is trapped intracellularly for glycolysis. **Clinical Pearl:** This is why muscle glycogen is for muscle's own use, while liver glycogen (and gluconeogenesis) sustains blood glucose for the whole body. ### Statement 4: PEPCK — TRUE Phosphoenolpyruvate carboxykinase catalyzes: $$\text{Oxaloacetate} + \text{GTP} \rightarrow \text{Phosphoenolpyruvate} + \text{GDP} + \text{CO}_2$$ PEPCK is a rate-limiting enzyme of gluconeogenesis. Its expression is: - **Induced by:** Glucagon, cortisol, thyroid hormone (fasting/stress signals) - **Repressed by:** Insulin (fed state) ## Regulatory Enzyme Comparison Table | Enzyme | Reaction | Activated By | Inhibited By | Role | |--------|----------|--------------|--------------|------| | **Pyruvate carboxylase** | Pyruvate → OAA | Acetyl-CoA | — | Committed step | | **Fructose-1,6-bisphosphatase** | F-1,6-BP → F-6-P | ATP, citrate | **AMP, ADP, F-2,6-BP** | Key regulatory step | | **Glucose-6-phosphatase** | G-6-P → Glucose | — | — | Final step; liver/kidney only | | **PEPCK** | OAA → PEP | Glucagon, cortisol | Insulin | Rate-limiting; induced in fasting | **Warning:** Do NOT confuse FBPase regulation with phosphofructokinase (PFK) regulation. PFK (glycolytic enzyme) is inhibited by ATP and citrate, and activated by AMP and F-2,6-BP — the opposite of FBPase.